Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
about
Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung CancerUse of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activationAutophagy as a modulator and target in prostate cancer.Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseCombination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell linesMetformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells.Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCsMetformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats.New insight for metformin against bladder cancer.New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.Metformin and prostate cancer stem cells: a novel therapeutic target.Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer CellsManagement Options for Biochemically Recurrent Prostate Cancer.Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration.Combinational strategies of metformin and chemotherapy in cancers.Metformin treatment reduces temozolomide resistance of glioblastoma cells.Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal CancerMetformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells.Triiodothyronine regulates distribution of thyroid hormone receptors by activating AMP-activated protein kinase in 3T3-L1 adipocytes and induces uncoupling protein-1 expression.Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis.Therapeutic strategies against cancer stem cells in human colorectal cancer.Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells.
P2860
Q28547364-500F2E21-4F9D-4374-9F70-2BC6B9858144Q33645356-11D357E4-481F-4AEF-90D2-1AF143FD33B8Q35557084-331580FF-2D62-4C4C-A3F5-855AF4B9F3BBQ35600122-D1979DC1-9479-42C3-824C-B5F4DAA7A35EQ35928999-5C3BF10E-6091-4050-BAE3-EC15BD8E45BCQ36217557-252E7535-B882-4227-B555-6CEAE1059D26Q36729549-46620703-1A98-4BF3-83A0-B898B8F2C517Q37091938-62153762-F474-4219-B192-E6F899800002Q37697040-4406E60C-22F9-44BB-98CD-B554B3738D7BQ37720435-BACCA069-816F-42D3-BC9A-80C8E945F73AQ37733377-ABB013B6-0A3A-4F3C-9702-24B79D8BBC5BQ38187997-123E7C7B-1707-4E2C-AE36-2025D400C7DDQ38555403-0E6EE733-5AA7-42B5-AA0D-17B84BE81017Q38635672-F999650E-7103-4D67-B80A-7F1A0A3C6F44Q38691937-56F87B2D-53F9-4E30-A832-E3059526A478Q38721748-A021D256-6461-41B0-BAE5-F9E79AEEBA51Q38816034-B8A48E60-181B-43CA-9302-1AEE871B4380Q38818730-E30F272B-3581-4616-BF1A-C14D1FCB8D93Q39239705-8C1BDF53-4B3D-4ACA-AB53-EB49C0724907Q39519100-F896F57B-7371-44A5-B14C-3A61A71328A3Q41345865-7C657732-4AE4-4329-B339-371E5090B07BQ42803482-6A54DD85-6972-4AEA-BE45-2036E32F9094Q46255692-3B3CE422-EB42-4E2E-93BA-52A33FE661A2Q47116201-3D2D42A0-F2C6-47A6-A3F1-818F6DAF257EQ47149854-5B87C6CE-F314-46DC-9C06-EF48DAC9EB7DQ49873927-EBF736E4-7647-4D4E-8AF1-108AD55F0985Q50001260-8AE3A377-6DB4-4A8D-B1D9-2EA989B02B5BQ55048037-C4D388BF-34D9-417D-B6BC-3AA8E664A5DF
P2860
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
@ast
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
@en
type
label
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
@ast
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
@en
prefLabel
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
@ast
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
@en
P2093
P2860
P1433
P1476
Effects of metformin on CD133+ colorectal cancer cells in diabetic patients
@en
P2093
Meiping Guan
Qian Zhang
Yanfei Zhang
Yaoming Xue
Zongji Zheng
P2860
P304
P356
10.1371/JOURNAL.PONE.0081264
P407
P577
2013-11-21T00:00:00Z